Altimmune stock: 48-week pemvidutide MASH data, FDA Breakthrough Therapy boost, but rising competition and cash needs. Click ...

A century after the Flexner Report, medical education faces its next revolution. Discover how AI agents are moving clinical ...

Local pollution cuts haven’t lowered ozone because transported pollution and global emissions now dominate exposure.

In 1910, Abraham Flexner exposed a medical education system riddled with inconsistency and weak scientific foundations. His report reshaped healthcare training by standardizing curricula, closing ...

The global market for synthetic chemicals is witnessing a strategic realignment, driven by shifting supply chains, heightened ...

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

REMSleep Holdings, Inc. (OTCQB: RMSL), a developer of the FDA-cleared DeltaWave(TM) nasal pillow system, today announced that it has received Healthcare Common Procedure Coding System (HCPCS) ...

Roche remains a Buy, driven by strong pipeline progress and conservative valuation, with shares up 36% since my last recommendation. Learn more about RHHBY stock here.

Patients with idiopathic pulmonary fibrosis-associated chronic cough who received twice-daily oral extended release nalbuphine for 6 weeks had decreases in 24-hour cough frequency, according to data ...

Despite receiving devices, education, and support, only one-third regularly took morning and night BP measurements as required.

Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent ...

KELOWNA, BC, Jan. 29, 2026 /CNW/ – Cantex Mine Development Corp. (TSXV: CD) (OTCQB: CTXDF) (the “Company”) is pleased to ...